These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12874094)

  • 1. Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension.
    Widlansky ME; Price DT; Gokce N; Eberhardt RT; Duffy SJ; Holbrook M; Maxwell C; Palmisano J; Keaney JF; Morrow JD; Vita JA
    Hypertension; 2003 Sep; 42(3):310-5. PubMed ID: 12874094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
    Hermann M; Camici G; Fratton A; Hurlimann D; Tanner FC; Hellermann JP; Fiedler M; Thiery J; Neidhart M; Gay RE; Gay S; Lüscher TF; Ruschitzka F
    Circulation; 2003 Nov; 108(19):2308-11. PubMed ID: 14597594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective COX-2 inhibition improves endothelial function in coronary artery disease.
    Chenevard R; Hürlimann D; Béchir M; Enseleit F; Spieker L; Hermann M; Riesen W; Gay S; Gay RE; Neidhart M; Michel B; Lüscher TF; Noll G; Ruschitzka F
    Circulation; 2003 Jan; 107(3):405-9. PubMed ID: 12551863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
    McAdam BF; Catella-Lawson F; Mardini IA; Kapoor S; Lawson JA; FitzGerald GA
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):272-7. PubMed ID: 9874808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats.
    Richter CM; Godes M; Wagner C; Maser-Gluth C; Herzfeld S; Dorn M; Priem F; Slowinski T; Bauer C; Schneider W; Neumayer HH; Kurtz A; Hocher B
    J Hypertens; 2004 Jan; 22(1):191-8. PubMed ID: 15106811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects.
    Dilger K; Herrlinger C; Peters J; Seyberth HW; Schweer H; Klotz U
    J Clin Pharmacol; 2002 Sep; 42(9):985-94. PubMed ID: 12211224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid potentiation of endothelium-dependent vasodilation by estradiol in postmenopausal women is mediated via cyclooxygenase 2.
    Calkin AC; Sudhir K; Honisett S; Williams MR; Dawood T; Komesaroff PA
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5072-5. PubMed ID: 12414874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension.
    Martínez-Revelles S; Avendaño MS; García-Redondo AB; Alvarez Y; Aguado A; Pérez-Girón JV; García-Redondo L; Esteban V; Redondo JM; Alonso MJ; Briones AM; Salaices M
    Antioxid Redox Signal; 2013 Jan; 18(1):51-65. PubMed ID: 22671943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.
    Rossat J; Maillard M; Nussberger J; Brunner HR; Burnier M
    Clin Pharmacol Ther; 1999 Jul; 66(1):76-84. PubMed ID: 10430112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
    Bensen WG; Fiechtner JJ; McMillen JI; Zhao WW; Yu SS; Woods EM; Hubbard RC; Isakson PC; Verburg KM; Geis GS
    Mayo Clin Proc; 1999 Nov; 74(11):1095-105. PubMed ID: 10560596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do COX-2 inhibitors reduce renal fibrosis?
    Harding P
    J Hypertens; 2004 Jan; 22(1):43-5. PubMed ID: 15106792
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.
    Bogaty P; Brophy JM; Noel M; Boyer L; Simard S; Bertrand F; Dagenais GR
    Circulation; 2004 Aug; 110(8):934-9. PubMed ID: 15302800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model.
    Khan AA; Brahim JS; Rowan JS; Dionne RA
    Clin Pharmacol Ther; 2002 Jul; 72(1):44-9. PubMed ID: 12152003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS
    J Rheumatol Suppl; 1999 Apr; 56():31-6. PubMed ID: 10225538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the cyclooxygenase-2 inhibitor celecoxib on bronchial responsiveness and cough reflex sensitivity in asthmatics.
    Dicpinigaitis PV
    Pulm Pharmacol Ther; 2001; 14(2):93-7. PubMed ID: 11273789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of specific COX-2 inhibition in rheumatoid arthritis.
    Lipsky PE; Isakson PC
    J Rheumatol Suppl; 1997 Jul; 49():9-14. PubMed ID: 9249645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors.
    White WB; Kent J; Taylor A; Verburg KM; Lefkowith JB; Whelton A
    Hypertension; 2002 Apr; 39(4):929-34. PubMed ID: 11967252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyclooxygenase-2 inhibitors on blood pressure.
    Johnson DL; Hisel TM; Phillips BB
    Ann Pharmacother; 2003 Mar; 37(3):442-6. PubMed ID: 12639178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.
    Hennan JK; Huang J; Barrett TD; Driscoll EM; Willens DE; Park AM; Crofford LJ; Lucchesi BR
    Circulation; 2001 Aug; 104(7):820-5. PubMed ID: 11502709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.